InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
JST Group HK$2.1 billion IPO
We advised JST Group on its IPO and HKEX listing
GenFleet Therapeutics HK$1.82 billion IPO
We advised GenFleet on its IPO and HKEX listing
Medtide HK$411.2 million IPO
We advised Medtide on its IPO and HKEX listing
Jiangsu Zenergy Battery Technologies HK$1.01 billion IPO
We advised Zenergy on its IPO and HKEX listing
BrainAurora Medical Technology HK$583 million IPO
We advised BrainAurora on its IPO and HKEX listing
ZEEKR Intelligent Technology $441 million IPO
We advised ZEEKR on its IPO and NYSE listing
CNOOC RMB28 billion Shanghai IPO
This is the largest A-share listing by an energy company in the last 15 years
Yili Group HK$1.66 billion privatization of China ZhongDi Dairy
We advised Yili, the largest dairy company in China, on the takeover and delisting of ZhongDi from the HKEX
CARsgen Therapeutics HK$3.1 billion IPO
We advised CARsgen Therapeutics on its IPO and HKEX listing